Publicaciones en colaboración con investigadores/as de Klinikum der Universität München (2)

2019

  1. Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

    Clinical Colorectal Cancer, Vol. 18, Núm. 3, pp. 183-191.e3

2017

  1. Exposure–response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial

    Cancer Chemotherapy and Pharmacology, Vol. 80, Núm. 3, pp. 599-608